Literature DB >> 21791609

Casein kinase 2 sends extracellular signal-regulated kinase nuclear.

Alan J Whitmarsh.   

Abstract

Mesh：

Substances：

Year:  2011        PMID： 21791609      PMCID： PMC3165549          DOI： 10.1128/MCB.05916-11

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN： 0270-7306            Impact factor:   4.272


× No keyword cloud information.
  13 in total

Review 1.  MAPK signal specificity: the right place at the right time.

Authors:  Leon O Murphy; John Blenis
Journal:  Trends Biochem Sci       Date:  2006-04-17       Impact factor: 13.807

2.  CK2 Is a component of the KSR1 scaffold complex that contributes to Raf kinase activation.

Authors:  Daniel A Ritt; Ming Zhou; Thomas P Conrads; Timothy D Veenstra; Terry D Copeland; Deborah K Morrison
Journal:  Curr Biol       Date:  2006-12-14       Impact factor: 10.834

3.  Human biliverdin reductase is an ERK activator; hBVR is an ERK nuclear transporter and is required for MAPK signaling.

Authors:  Nicole Lerner-Marmarosh; Tihomir Miralem; Peter E M Gibbs; Mahin D Maines
Journal:  Proc Natl Acad Sci U S A       Date:  2008-05-07       Impact factor: 11.205

4.  PORE-ing over ERK substrates.

Authors:  Natalie G Ahn
Journal:  Nat Struct Mol Biol       Date:  2009-10       Impact factor: 15.369

5.  Nuclear extracellular signal-regulated kinase 1 and 2 translocation is mediated by casein kinase 2 and accelerated by autophosphorylation.

Authors:  Alexander Plotnikov; Dana Chuderland; Yael Karamansha; Oded Livnah; Rony Seger
Journal:  Mol Cell Biol       Date:  2011-07-05       Impact factor: 4.272

6.  Nuclear entry of activated MAPK is restricted in primary ovarian and mammary epithelial cells.

Authors:  Elizabeth R Smith; Kathy Qi Cai; Jennifer L Smedberg; Melina M Ribeiro; Malgorzata E Rula; Carolyn Slater; Andrew K Godwin; Xiang-Xi Xu
Journal:  PLoS One       Date:  2010-02-18       Impact factor: 3.240

7.  EGF-induced ERK activation promotes CK2-mediated disassociation of alpha-Catenin from beta-Catenin and transactivation of beta-Catenin.

Authors:  Haitao Ji; Ji Wang; Heinz Nika; David Hawke; Susan Keezer; Qingyuan Ge; Bingliang Fang; Xuexun Fang; Dexing Fang; David W Litchfield; Kenneth Aldape; Zhimin Lu
Journal:  Mol Cell       Date:  2009-11-25       Impact factor: 17.970

8.  Identification and characterization of a general nuclear translocation signal in signaling proteins.

Authors:  Dana Chuderland; Alexander Konson; Rony Seger
Journal:  Mol Cell       Date:  2008-09-04       Impact factor: 17.970

Review 9.  The subcellular localization of MEK and ERK--a novel nuclear translocation signal (NTS) paves a way to the nucleus.

Authors:  Eldar Zehorai; Zhong Yao; Alexander Plotnikov; Rony Seger
Journal:  Mol Cell Endocrinol       Date:  2009-05-04       Impact factor: 4.102

10.  Glycogen synthase kinase 3 beta (GSK3β) phosphorylates the RNAase III enzyme Drosha at S300 and S302.

Authors:  Xiaoli Tang; Ming Li; Lynne Tucker; Bharat Ramratnam
Journal:  PLoS One       Date:  2011-06-03       Impact factor: 3.240
View more
  4 in total

Review 1.  CK2 and the Hallmarks of Cancer.

Authors:  May-Britt Firnau; Angela Brieger
Journal:  Biomedicines       Date:  2022-08-16

2.  CD5-CK2 Signaling Modulates Erk Activation and Thymocyte Survival.

Authors:  Carlos A Mier-Aguilar; Kevin S Cashman; Chander Raman; Gloria Soldevila
Journal:  PLoS One       Date:  2016-12-28       Impact factor: 3.240

Review 3.  The Role of Protein Kinase CK2 in Development and Disease Progression: A Critical Review.

Authors:  Daniel Halloran; Venu Pandit; Anja Nohe
Journal:  J Dev Biol       Date:  2022-07-27

Review 4.  Role of protein kinases CK1α and CK2 in multiple myeloma: regulation of pivotal survival and stress-managing pathways.

Authors:  Sabrina Manni; Marilena Carrino; Francesco Piazza
Journal:  J Hematol Oncol       Date:  2017-10-02       Impact factor: 17.388
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.